Organometallics
Article
The crude mixture was purified via column chromatography (silica,
CH2Cl2), to give the product as a light yellow solid (104 mg, 69%).
Mp: >230 °C. IR: ν (cm−1) 3035, 2976, 2935, 2838, 1610, 1574, 1474,
1438, 1420, 1395, 1386, 1313, 1292, 1255, 1178, 1143, 1093, 1076,
1022, 888, 827, 806, 749, 694, 653, 614, 594, 549, 518. 1H NMR (500
MHz, CDCl3): δ 7.93 (d, J = 10 Hz, 2H, Hi), 7.76 (d, J = 10 Hz, 2H,
Hk), 7.50 (m, 2H, Hb), 7.43 (t, J = 10 Hz, 2H, Hl), 7.38 (t, J = 5 Hz,
1H, Hm), 7.15 (m, 2H, Ha), 7.09 (d, J = 10 Hz, 2H, Hh), 6.09 (s, 2H,
Hn), 6.06 (spt, J = 7 Hz, 1H, Hd), 6.05 (spt, J = 7 Hz, 1H, Hf), 3.96 (s,
3H, Hj), 3.91 (s, 3H, Hg), 1.71 (d, J = 7 Hz, 6H, He), 1.64 (d, J = 7 Hz,
6H, Hc). 13C NMR (125 MHz, CDCl3): δ 180.44 (s, Ccarbene(bimy)),
160.62, 159.00 (s, Ccarbene(trz)), 145.17, 134.80, 133.76, 132.25, 129.44,
128.89, 128.60, 121.84, 121.83, 120.64, 113.94, 112.56, 58.48, 55.55,
53.79, 53.59, 36.99, 21.20, 21.06. HR-ESI-MS: m/z 770.0095 [8b +
Na]+ (calcd for C30H35Br2N5NaOPd 770.0128), 726.0625 [PdBr(Cl)-
(iPr2-bimy)(trz-b) + Na]+ (calcd for C30H35BrClN5NaOPd 726.0623),
668.1040 [8b-Br−]+ (calcd for C30H35BrN5OPd 668.1038), 624.1547
[PdCl(iPr2-bimy)(trz-b)]+ (calcd for C30H35ClN5OPd 624.1563),
586.1810 [Pd(iPr2-bimy)(trz-b) − H]+ (calcd for C30H34N5OPd
586.1804), 358.0563 [(trz-b) + Br]+ (calcd for C17H17BrN3O
358.0555). Anal. Calcd for C30H35Br2N5OPd: C, 48.18; H, 4.72; N,
9.36. Found: C, 48.39; H, 4.70; N, 9.38.
7.37 (t, J = 8 Hz, 3H, Hi,j), 7.28 (t, J = 8 Hz, 1H, Hn), 7.16 (m, 2H,
Ha), 6.13 (s, 2H, Ho), 6.05 (spt, J = 7 Hz, 1H, Hd), 5.93 (spt, J = 7 Hz,
1H, Hf), 4.62 (s, 2H, Hg), 3.78 (s, 3H, Hk), 1.66 (d, J = 7 Hz, 6H, Hc),
1.64 (d, J = 7 Hz, 6H, He). 13C NMR (125 MHz, CDCl3): δ 179.70 (s,
Ccarbene(bimy)), 158.99 (s, Ccarbene(trz)), 144.23, 136.83, 135.34, 133.84,
133.76, 129.04, 129.02, 128.85, 128.65, 128.36, 127.07, 121.86, 112.59,
58.07, 53.74, 36.31, 31.85, 21.05. HR-ESI-MS: m/z 754.0122 [8d +
Na]+ (calcd for C30H35Br2N5NaPd 754.0179), 710.0593 [PdBr(Cl)-
(iPr2-bimy)(trz-d) + Na]+ (calcd for C30H35BrClN5NaPd 710.0674),
652.1047 [8d − Br−]+ (calcd for C30H35BrN5Pd 652.1088), 344.0554
[(trz-d) + Br]+ (calcd for C17H17BrN3 344.0580). Anal. Calcd for
C30H35Br2N5Pd: C, 49.23; H, 4.82; N, 9.57. Found: C, 49.48; H, 5.03;
N, 9.52.
Synthesis of Pd(II) Complex 8e. Bis(μ-bromo)bis(1,3-diisopro-
pylbenzimidazolin-2-ylidene)dibromopalladium(II) (94 mg, 0.100
mmol, 1.0 equiv) and TBAB (68 mg, 0.211 mmol, 2.1 equiv) were
heated at reflux in CHCl3 (5 mL) for 3 h. The solvent was removed in
vacuo, the orange powder was redissolved in CH2Cl2 (15 mL), and
then Ag2O (28 mg, 0.121 mmol, 1.2 equiv) and 6e (68 mg, 0.210
mmol, 2.1 equiv) were added. The reaction mixture was stirred at
room temperature for 24 h and then filtered through Celite. The
filtrate was washed with H2O (4 × 50 mL) and the aqueous layer
discarded. The organic layer was removed in vacuo, and the yellow
residue was purified via column chromatography (silica, 9/1 CH2Cl2/
acetone), to give the product as a yellow solid (91 mg, 64%). Mp:
>230 °C. IR: ν (cm−1) 3058, 3006, 2979, 2935, 2880, 1594, 1497,
1474, 1423, 1401, 1388, 1369, 1315, 1261, 1175, 1143, 1093, 1074,
1020, 924, 778, 765, 749, 703, 692, 681, 604, 547, 522, 484. 1H NMR
(500 MHz, CDCl3): δ 8.49 (d, J = 10 Hz, 2H, Hk), 8.14 (d, J = 10 Hz,
2H, Hi), 7.62 (m, 6H, Hl/m/h/g), 7.47 (m, 2H, Hb), 7.13 (dd, J = 8 Hz,
2H, Ha), 5.87 (spt, J = 7 Hz, 1H, Hd/f), 5.86 (spt, J = 7 Hz, 1H, Hd/f),
4.15 (s, 3H, Hj), 1.62 (d, J = 7 Hz, 6H, Hc/e), 1.58 (d, J = 7 Hz, 6H,
Hc/e). 13C NMR (125 MHz, CDCl3): δ 179.87 (s, Ccarbene(bimy)),
160.08 (s, Ccarbene(trz)), 145.25, 140.11, 133.80, 133.67, 131.00, 129.82,
129.75, 128.88, 128.64, 128.20, 125.75, 121.82, 112.49 53.68, 53.58,
37.35, 21.03, 21.02. HR-ESI-MS: m/z 1430.9643 [2(8e) + Na]+ (calcd
for C56H62Br4N10NaPd2 1430.9823), 1327.0628 [8e+(8e-Br−)]+
(calcd for C56H62Br3N10Pd 1327.0762), 725.9799 [8e + Na]+ (calcd
for C28H32Br2N5NaPd 725.9858), 624.0727 [8e − Br−]+ (calcd for
C28H31BrN5Pd 624.0777), 578.1231 [PdCl(iPr2-bimy)(trz-e)]+ (calcd
for C28H31ClN5Pd 578.1303). Anal. Calcd for C28H31Br2N5Pd: C,
47.78; H, 4.44; N, 9.95. Found: C, 47.74; H, 4.37; N, 9.96.
Synthesis of Pd(II) Complex 8c. Bis(μ-bromo)bis(1,3-diisopro-
pylbenzimidazolin-2-ylidene)dibromopalladium(II) (94 mg, 0.100
mmol, 1.0 equiv) and TBAB (66 mg, 0.204 mmol, 2.0 equiv) were
heated at reflux in CHCl3 (5 mL) for 4 h. The solvent was removed in
vacuo, the orange powder was redissolved in CH2Cl2 (15 mL), and
then Ag2O (28 mg, 0.121 mmol, 1.2 equiv) and 6c (98 mg, 0.202
mmol, 2.0 equiv) were added. The reaction mixture was stirred at
room temperature for 36 h and then filtered through Celite. The
filtrate was washed with H2O (5 × 50 mL) and the aqueous layer
discarded. The organic layer was removed in vacuo, and the resulting
yellow residue was purified via column chromatography (silica,
CH2Cl2), to give the product as a yellow solid (104 mg, 68%). Mp:
>230 °C. IR: ν (cm−1) 3093, 3063, 3029, 2971, 2937, 2879, 1601,
1518, 1456, 1420, 1398, 1386, 1358, 1343, 1312, 1142, 1092, 1078,
1023, 865, 856, 757, 704, 647, 598, 547, 496, 458, 424. 1H NMR (500
MHz, CDCl3): δ 8.43 (d, J = 10 Hz, 2H, Hg), 8.28 (d, J = 10 Hz, 2H,
Hh), 7.74 (d, J = 8 Hz, 2H, Hj), 7.51 (dd, J = 7, 3 Hz, 2H, Hb), 7.45 (t,
J = 8 Hz, 2H, Hk), 7.40 (m, J = 8 Hz, 1H, Hl), 7.17 (dd, J = 7, 3 Hz,
2H, Ha), 6.15 (s, 2H, Hm), 5.97 (m, J = 7 Hz, 2H, Hd/f), 4.06 (s, 3H,
Hi), 1.70 (d, J = 7 Hz, 6H, Hc), 1.65 (d, J = 7 Hz, 6H, He). 13C NMR
(125 MHz, CDCl3): δ 178.95 (s, Ccarbene(bimy)), 161.91 (s, Ccarbene(trz)),
148.50, 143.44, 134.89, 134.36, 133.67, 131.81, 129.30, 129.00, 128.83,
123.65, 122.05, 112.66, 58.72, 53.92, 53.75, 37.53, 21.11, 21.02. HR-
Synthesis of Pd(II) Complex 8f. Bis(μ-bromo)bis(1,3-diisopro-
pylbenzimidazolin-2-ylidene)dibromopalladium(II) (93 mg, 0.099
mmol, 1.0 equiv) and TBAB (68 mg, 0.211 mmol, 2.1 equiv) were
heated at reflux in CHCl3 (5 mL) for 3 h. The solvent was removed in
vacuo, the orange powder was redissolved in CH2Cl2 (15 mL), and
then Ag2O (36 mg, 0.155 mmol, 1.6 equiv) and 6f (89 mg, 0.219
mmol, 2.2 equiv) were added. The reaction mixture was stirred at
room temperature for 18 h. After this time the reaction mixture was
filtered through Celite, the solvent of the filtrate was removed in
vacuo, and the crude mixture was purified via column chromatography
(silica, 9/1 CH2Cl2/acetone) to give the product as a yellow solid (112
mg, 72%). Mp: >230 °C. IR: ν (cm−1) 3056, 2975, 2919, 1612, 1475,
1422, 1401, 1369, 1315, 1271, 1183, 1142, 1093, 1062, 1022, 846, 740,
ESI-MS: m/z 1548.9823 [2(8c)
+
Na]+ (calcd for
C58H64Br4N12NaO4Pd2 1548.9854), 1503.0305 [8c+PdBr(Cl)(iPr2-
bimy)(trz-c) + Na]+ (calcd for C58H64Br3ClN12NaO4Pd2 1503.0366),
784.9826 [8c + Na]+ (calcd for C29H32Br2N6NaO2Pd 784.9873),
741.0341 [PdBr(Cl)(iPr2-bimy)(trz-c) + Na]+ (calcd for
C29H32BrClN6NaO2Pd 741.0368), 683.0756 [8c − Br−]+ (calcd for
C29H32BrN6O2Pd 683.0783), 373.0254 [(trz-c) + Br]+ (calcd for
−
+
C16H14BrN4O4 373.0295), 295.1178 [6c − BF4
]
(calcd for
C16H15N4O2 295.1190). Anal. Calcd for C29H33Br2N6O2Pd: C,
45.66; H, 4.23; N, 11.02. Found: C, 45.96; H, 4.26; N, 11.02.
1
Synthesis of Pd(II) Complex 8d. Bis(μ-bromo)bis(1,3-diisopro-
pylbenzimidazolin-2-ylidene)dibromopalladium(II) (93 mg, 0.099
mmol, 1.0 equiv) and TBAB (67 mg, 0.208 mmol, 2.0 equiv) were
heated at reflux in CHCl3 (5 mL) for 4 h. The solvent was removed in
vacuo, the orange powder was redissolved in CH2Cl2 (15 mL), and
then Ag2O (30 mg, 0.129 mmol, 1.3 equiv) and 6d (98 mg, 0.198
mmol, 2.0 equiv) were added. The reaction mixture was stirred at
room temperature for 24 h and then filtered through Celite. The
filtrate was removed in vacuo and the crude mixture purified via
column chromatography (silica, CH2Cl2), to give the product as a light
yellow solid (101 mg, 70%). Mp: >230 °C. IR: ν (cm−1) 3088, 2976,
2935, 2873, 1602, 1584, 1495, 1474, 1454, 1420, 1396, 1387, 1312,
1231, 1175, 1141, 1093, 1074, 848, 807, 750, 736, 729, 713 695, 548,
456. 1H NMR (500 MHz, CDCl3): δ 7.66 (d, J = 7 Hz, 2H, Hl), 7.57
(d, J = 8 Hz, 2H, Hh), 7.50 (m, 2H, Hb), 7.43 (t, J = 7 Hz, 2H, Hm),
564. H NMR (500 MHz, CDCl3): δ 7.36 (dd, J = 6, 4 Hz, 2H, Hb),
7.07 (m, 6H, Ha/h/l), 5.56 (spt, J = 6 Hz, 2H, Hd/f), 3.87 (s, 3H, Hj),
2.43 (s, 3H, Hg/m), 2.41 (s, 3H, Hg/m), 2.37 (s, 6H, Hi/k), 2.36 (s, 6H,
Hi/k), 1.50 (d, J = 7 Hz, 12H, Hc/e). 13C NMR (125 MHz, CDCl3): δ
178.99 (s, Ccarbene(bimy)), 162.32 (s, Ccarbene(trz)), 144.94, 139.79, 139.62,
136.37, 136.10, 133.89, 128.91, 128.51, 124.18, 121.56, 112.08, 53.23,
36.04, 21.60, 21.47, 21.37, 21.02, 19.56. HR-ESI-MS: m/z 1599.1626
[2(8f) + Na]+ (calcd for C68H86Br4N10NaPd2 1559.1722), 1553.2211
[8f
+ PdBr(Cl)(iPr2 -bimy)(trz-f) +
Na]+ (calcd for
C68H86Br3ClN10NaPd2 1553.2233), 810.0739 [8f + Na]+ (calcd for
C34H43Br2N5NaPd 810.0806), 766.1233 [PdBr(Cl)(iPr2-bimy)(trz-f)
+ Na]+ (calcd for C34H43BrClN5NaPd 766.1300), 708.1665 [8f −
−
Br−]+ (calcd for C34H43BrN5NaPd 708.1715), 320.2082 [6f − BF4 ]+
(calcd for C21H26N3 320.2121). Anal. Calcd for C34H43Br2N5Pd: C,
51.83; H, 5.50; N, 8.89. Found: C, 51.81; H, 5.54; N, 8.87.
7073
dx.doi.org/10.1021/om400773n | Organometallics 2013, 32, 7065−7076